2m 2m 2m 2m 2m 2m 2m
Neurocrine Biosc (NBIX)
NASDAQ
$172.50-$1.91 (-1.10%)
Price as of Nov 12, 2026 8:38 AM EST- $17.7BMarket Cap
- 18.77%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Neurocrine Biosc (NBIX)
$172.50-$1.91 (-1.10%)
NBIX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $174.41 | ||
Change | +$5.27 (+3.12%) | ||
Open | $168.92 | ||
High | $174.59 | ||
Low | $168.09 | ||
Previous Close | $169.14 | ||
Volume | 1,144,586 | ||
30-Day Average Volume | 1,368,536 | ||
1-Week Change | 5.03% | ||
1-Month Change | 22.44% | ||
1-Year Change | 18.77% | ||
3-Year Change | 62.74% | ||
5-Year Change | 95.46% | ||
Fundamentals | |||
Shares Outstanding | 101.2M | ||
Total Assets | $5.6B | ||
Market Cap | $17.7B | ||
Enterprise Value | $17.0B | ||
Period: QTR TTM FY | |||
Revenue | $1.1B | ||
Net Income | $206.5M | ||
Free Cash Flow | $383.6M | ||
EBIT | $286.9M | ||
EBITDA | $321.9M | ||
Net Working Capital | $1.0B | ||
EPS | $1.96 | ||
Enterprise Value/EBITDA | 53 | ||
Enterprise Value/Revenue | 15 | ||
P/B | 5 | ||
P/E | 89 | ||
PEG | 2 | ||
Price/Free Cash Flow | 46 | ||
Price/Operating Cash Flow | 45 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue